Quick Takeaways
- AdvisorShares Trust filed SCHEDULE 13G/A for PSYENCE BIOMEDICAL LTD. Common Shares, no par value (PBM).
- Disclosed ownership: 0.79%.
- Date of event: 31 Dec 2024.
AdvisorShares Trust - 31 Dec 2024 SCHEDULE 13G/A Report for PSYENCE BIOMEDICAL LTD. Common Shares, no par value (PBM)
- Filing Manager
- AdvisorShares Trust
- Reporting Manager
- AdvisorShares Trust
- Symbol
- PBM
- Shares outstanding
- 3,408,070 shares
- Disclosed Ownership
- 26,924 shares
- Ownership
- 0.79%
- Form type
- SCHEDULE 13G/A
- Filing time
- 06 Jan 2025, 17:05:39 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"AdvisorShares Trust disclosed 0.79% ownership in PSYENCE BIOMEDICAL LTD. Common Shares, no par value (PBM) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 06 Jan 2025, 17:05.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| AdvisorShares Trust | 0.79% | 26,924 | 26,924 | 0 | /s/ Stefanie Little | Stefanie Little - Chief Compliance Officer |